# EDGAR Filing Document

**Accession Number:** 0001835268
**File Stem:** 0001912836-26-000001
**Filing Date:** 2026-4
**Character Count:** 9860
**Document Hash:** ddf2287cc3ef20f2632337fab45c38a4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001912836-26-000001.hdr.sgml**: 20260414

**ACCESSION NUMBER**: 0001912836-26-000001

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260414

**DATE AS OF CHANGE**: 20260414

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Connect Biopharma Holdings Ltd
- **CENTRAL INDEX KEY:** 0001835268
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92416
- **FILM NUMBER:** 26859731

**BUSINESS ADDRESS:**
- **STREET 1:** 3580 CARMEL MOUNTAIN ROAD, SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
- **BUSINESS PHONE:** 858-727-1040

**MAIL ADDRESS:**
- **STREET 1:** 3580 CARMEL MOUNTAIN ROAD, SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BioFortune Inc
- **CENTRAL INDEX KEY:** 0001912836

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** COASTAL BLDG WICKHAMS CAY II
- **STREET 2:** PO BOX 2221
- **CITY:** ROAD TOWN TORTOLA
- **STATE:** D8
- **ZIP:** NONE
- **BUSINESS PHONE:** 86 512 5357 7866

**MAIL ADDRESS:**
- **STREET 1:** COASTAL BLDG WICKHAMS CAY II
- **STREET 2:** PO BOX 2221
- **CITY:** ROAD TOWN TORTOLA
- **STATE:** D8
- **ZIP:** NONE

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Connect Biopharma Holdings Ltd

**Title of Class of Securities:** Ordinary Shares, par value $0.000174 per share

**CUSIP Number:** —

**Date of Event Which Requires Filing of this Statement:** 04/14/2026

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [ ] Rule 13d-1(c)

- [x] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>BioFortune Inc | Names of Reporting Persons<br>BioFortune Inc |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>D8 | Citizenship or Place of Organization<br>D8 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>5987431.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>5987431.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>5987431.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>5987431.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.5% | Percent of Class Represented by Amount in Row (9)<br>9.5% |
| 12. | Type of Reporting Person (See Instructions)<br>CO | Type of Reporting Person (See Instructions)<br>CO |

---

| 1. | Names of Reporting Persons<br>Wubin Pan | Names of Reporting Persons<br>Wubin Pan |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>Z4 | Citizenship or Place of Organization<br>Z4 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>6026813.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>6026813.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>6026813.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>6026813.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.6% | Percent of Class Represented by Amount in Row (9)<br>9.6% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

---

**Item 1(a). Name of Issuer:**
Connect Biopharma Holdings Ltd

**Item 1(b). Address of Issuer's Principal Executive Offices:**
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CALIFORNIA, 92130.

**Item 2(a). Name of Person Filing:**
Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of:

Biofortune Inc.

Wubin Pan

**Item 2(b). Address of Principal Business Office:**
The registered address of Biofortune Inc. is c/o Biofortune Inc., Coastal Building, Wickham's Cay II, P.O. Box 2221, Road Town, Tortola, British Virgin Islands. The business address of the reporting person is: Suite 103, Building #3, Shu-Yuan Road No. 99, Taicang, JiangSu Province, China

**Item 2(c). Citizenship:**
Biofortune Inc. is organized under the laws of the British Virgin Islands, Wubin Pan is a citizen of Canada.

**Item 2(d). Title of Class of Securities:**
Ordinary Shares, par value $0.000174 per share

**Item 2(e). CUSIP Number:**
—

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

Mr. Pan is the beneficial owner of 6,026,813 Ordinary Shares, which consist of (i) 5,987,431 Ordinary Shares held of record by Biofortune Inc. and (ii) 39,382 Ordinary Shares held of record by Mr. Pan?s spouse. Mr. Pan is the sole shareholder of Biofortune Inc. As a result, Mr. Pan may be deemed to share beneficial ownership over the securities held of record by Biofortune Inc.

**(b) Percent of class:**

Biofortune Inc.:9.5%
Wubin Pan: 9.6%
Note: The ownership information presented herein represents beneficial ownership of Ordinary Shares as of March 31, 2026, based upon 62,651,282 Ordinary Shares outstanding as disclosed in the Issuer?s Form 10-K and Form 8-K filed with SEC on March 31, 2026.

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

Biofortune Inc.:0
Wubin Pan: 0

**(ii) Shared power to vote or to direct the vote:**

Biofortune Inc.: 5,987,431
Wubin Pan: 6,026,813

**(iii) Sole power to dispose or to direct the disposition of:**

Biofortune Inc.:0
Wubin Pan: 0

**(iv) Shared power to dispose or to direct the disposition of:**

Biofortune Inc.: 5,987,431
Wubin Pan: 6,026,813

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

—

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**BioFortune Inc**

**Date:** 04/14/2026

**By:** Wubin Pan

**Name & Title:** Wubin Pan, Director

**Wubin Pan**

**Date:** 04/14/2026

**By:** Wubin Pan

**Name & Title:** Wubin Pan